Last updated on January 2014

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Favipiravir in Adult Subjects with Uncomplicated Influenza


Brief description of study

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Favipiravir in Adult Subjects with Uncomplicated Influenza

Detailed Study Description

A 5 day trial evaluating Favipiravir (oral medication) vs. placebo in patients with the Flu.

Clinical Study Identifier: TX137747

Find a site near you

Start Over

California Center for Clinical Research

207 S. Santa Anita St.<br /> Suite G16 San Gabriel, CA USA
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.